Medical Device Patent News for November 14

Send Email

The latest advancements in the medical world include devices that are focused on invasive, internal uses of technology to limit surgical trauma and improve the function of implanted instruments. These accomplishments have recently received medical device patent approvals and are well on their way to changing the look of modern medicine.


Soulor Surgical, a collaboration of Dr. Roger Brecheen and engineer Jack Koehler, has obtained a medical patent approval for a surgical instrument they designed for use in noninvasive gynecological surgeries. The device was specifically created to be used in laparoscopic hysterectomies, which reduce the recovery time from weeks to days. The device is being used in clinical trials at Dr. Brecheen’s home of Powell Valley Healthcare, along with Harvard, Stanford and several other national universities. These trials are expected to lead to full approval from the Federal Drug Administration. 


Titan Medical has also made surgical advancements with the patent approval of its robotic system for medical procedures. The patent protects the methodology and the complete robotic system, which allows for both a smaller incision and is capable of constantly monitoring the pressure of the device and gather data during the procedure. Titan Medical currently has five patents for their work in medical robotics and is actively seeking approval for additional advancements in this area.


Micell Technologies has made great strides in potentially improving the safety and use of stents in cardiovascular patients. The MiStent SES includes their medical patent technology that uses a special coating consisting of an approved polymer and drug combination. This coating improves the ability for the stent to release the drug into the surrounding tissue in a controlled and sustained process. The approval of this medical device patent is believed to lead to several other patents already submitted.


SpinalCycle, LLC has been given a patent for their work with spinal disc regeneration. Their methodology and scaffolding structure combine to allow the human body to regenerate the nucleus of the spinal disc. The scaffolding system allows vertebra pressure to be transferred to the nucleus, allowing it to support the spinal system by distributing pressure. This technology has successfully passed through its first round of animal trials and is well on its way to positively impacting the future of spinal surgery.

“Powell Doctor Gets Patent for Minimally Invasive Gynecologic Surgical Instrument”


“Titan Medical Granted Fifth Patent Around Surgical Robotics”


“Micell Technologies Announces Issuance of Core Technology Patent”


“SpinalCyte, LLC Receives U.S. Patent for Spinal Disc Regeneration”

Trackbacks (0) Links to blogs that reference this article Trackback URL
Send To A Friend Use this form to send this entry to a friend via email.